Previous 10 | Next 10 |
Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...
Organon & Co. (OGN) is expected to report $1.04 for Q3 2023
2023-11-01 12:56:56 ET More on Organon Organon: The Federal Reserve Black Swan (Rating Upgrade) 6% Yield And Significantly Undervalued: A Closer Look At Organon Organon Q2 2023 Earnings Review: Incremental Growth With A Slather Of Risk Hennessy Funds is bulli...
Organon (NYSE:OGN) and Sempre Health today announced a strategic partnership designed to motivate eligible patients to refill their prescriptions on time and improve adherence through an innovative pricing program that offers personalized support. This press release features multimedia. View ...
2023-10-29 08:28:00 ET As the calendar turns from October to November, the week promises a flurry of earnings reports from some of the world's most prominent companies. Among the key players stepping into the earnings spotlight will be technology giant Apple ( NASDAQ: AAPL ), semico...
Organon Canada Announces Availability of a High-Concentration, Citrate-Free Formulation of HADLIMA®, a Biosimilar to HUMIRA* Canada NewsWire HADLIMA ® 40 mg/0.4 mL offers a higher concentration compared to HADLIMA ® 40 mg/0.8 mL The availabilit...
Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, will release its third quarter 2023 financial results on November 2, 2023, prior to the company’s webcast and conference call scheduled for 8:30 a.m. EST. Interested parties may access the live call via...
2023-10-18 10:30:00 ET Summary Miller Value Partners is a value investor. It values businesses, and not just stocks, and invests in them for the long term. The Miller Income Strategy outperformed the ICE BofA High Yield index in Q3 2023, despite the broader decline in securities m...
2023-10-16 14:48:23 ET The market is in very good shape, said Hennessy Funds’ chief market strategist Neil Hennessy. In a CNBC interview on Monday, he pointed out that all three indexes are up. ( DJI ) up 13.07%, compared to last year. ( SP500 ) up 19.13%, compa...
2023-10-16 10:59:42 ET More on Dare Bioscience Seeking Alpha’s Quant Rating on Dare Bioscience Dare Bioscience to sell 10M shares at $0.70 in registered direct offering Historical earnings data for Dare Bioscience For further details see: Daré...
News, Short Squeeze, Breakout and More Instantly...
VANCOUVER, BC / ACCESSWIRE / July 31, 2024 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce a new significant gold-silver discovery, called the Navidad vein system, on the Ermitaño Mine concessions in Sonora, Mexico where the Company holds a...
VANCOUVER, BC / ACCESSWIRE / July 24, 2024 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce updates for its partner funded exploration stage projects and royalties. Highlights Estimated 30,000 metres of drilling in seven planned or comp...
Company estimates $15 million of milestone expense in the second quarter Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, will release its second quarter 2024 financial results on August 6, 2024, prior to the company’s webcast and conference...